 |
Massimo Pizzato is Full Professor at the Department of Cellular, Computational and Integrative Biology of the University of Trento, Italy. He obtained his PhD from the Institute of Cancer Research in London (UK) in 1999, followed by postdoctoral research at the Cancer Immunology and AIDS Department of the Dana-Farber Cancer Institute, Harvard Medical School, Boston (USA). He subsequently held academic positions at Imperial College London and at the University of Geneva before joining the University of Trento, where he became Associate Professor in 2015 and Full Professor in 2020. He has served as Director of the Degree Program in Medicine and Surgery and Deputy Director of the Interdepartmental Center for Medical Sciences (CisMed). His research focuses on virology and immunology, with particular interest in virus–host interactions, innate immunity, and vaccine development against emerging pathogens. His work led to the identification of the antiviral factor SERINC5, for which he received the prestigious Max von Pettenkofer International Prize in 2017. Professor Pizzato serves as editor for the scientific journals Virology and Frontiers in Virology. |